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AbstrACt
Objective We identified mechanisms for addressing and/
or managing the influence of corporations on public health 
policy, research and practice, as well as examples of 
where these mechanisms have been adopted from across 
the globe.
Design We conducted a scoping review. We conducted 
searches in five databases on 4 June 2019. Twenty- 
eight relevant institutions and networks were contacted 
to identify additional mechanisms and examples. In 
addition, we identified mechanisms and examples from 
our collective experience working on the influence 
of corporations on public health policy, research and 
practice.
setting We identified mechanisms at the national, 
regional and global levels.
results Thirty- one documents were included in our 
review. Eight were peer- reviewed scientific articles. 
Nine discussed mechanisms to address and/or manage 
the influence of different types of industries; while 
other documents targeted specific industries. In total, 
we identified 49 mechanisms for addressing and/or 
managing the influence of corporations on public health 
policy, research and practice, and 43 of these were 
adopted at the national, regional or global level. We 
identified four main types of mechanisms: transparency; 
management of interactions with industry and of conflicts 
of interest; identification, monitoring and education about 
the practices of corporations and associated risks to 
public health; prohibition of interactions with industry. 
Mechanisms for governments (n=17) and academia 
(n=13) were most frequently identified, with fewer for the 
media and civil society.
Conclusions We identified several mechanisms that could 
help address and/or manage the negative influence of 
corporations on public health policy, research and practice. 
If adopted and evaluated more widely, many of the 
mechanisms described in this manuscript could contribute 
to efforts to prevent and control non- communicable 
diseases.
trial registration details The protocol was registered 
with the Open Science Framework on 27 May 2019 
(https:// osf. io/ xc2vp).
bACkgrOunD
There is growing evidence, coupled with 
public awareness, that the economic power of 
corporations, particularly that of large trans-
nationals, has led to the defeat, delay and 
weakening of public health policies around 
the world.1–3 Perhaps the best evidence of the 
harmful influence of corporations on public 
health policy is in the field of tobacco control. 
In the 1990s, during litigation in the USA, 
leading tobacco companies released large 
quantities of internal documents,4 5 revealing 
how, over decades, they sought to deny the 
threat that tobacco posed to health and to 
thwart measures to reduce smoking.6–8 Recent 
research has shown that influence of tobacco 
industry has resulted in a policy shift towards 
industry interests in some regions, such as the 
European Union.9 Tobacco continues to kill 
millions.10 An emerging body of evidence is 
revealing the use of similar corporate efforts 
to defeat, delay and weaken the public health 
strengths and limitations of this study
 ► This review is the first attempt to develop an inven-
tory of mechanisms for addressing and managing 
the influence of corporations on public health policy, 
research and practice.
 ► Many of the mechanisms identified in our review 
have been developed with no restriction on the type 
of industries targeted.
 ► The list compiled here is non- exhaustive and by na-
ture, subject to changes, as an increasing number of 
governments and other institutions take measures 
to prevent undue influence from industry.
 ► Not all mechanisms have yet been thoroughly evalu-
ated; therefore, we did not assess the validity of the 
included studies.
 ► Mechanisms at the subnational level have not been 
included in our study.
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policies and influence research and practice, from a 
range of sectors including the alcohol, food, gambling, 
oil and pharmaceutical industries, among others.1 11–15 
These corporate practices that have a negative impact on 
health, and that are used across industries, are increas-
ingly referred to as ‘commercial determinants of health’ 
in the literature.16
Industry efforts to influence public policy, research 
and practice are often referred to as ‘corporate political 
activity’ (CPA). The CPA includes: coalition management 
(influence on third parties such as health organisations, 
communities and the media); information management 
(manipulation of the evidence base, through the funding 
of research, ghost- writing, and so on); direct and indirect 
involvement in policy- making; litigation or the threat of 
legal actions; and discursive strategies seeking to frame 
the dominant narrative in their favour.8
Several institutions have been established to monitor 
the influence of corporations on public health policy, 
research and practice, such as Corporate Europe Obser-
vatory in Europe and US Right to Know in the USA (see 
online supplementary file 1 for a non- exhaustive list 
of such organisations). Major reviews of the determi-
nants of health also increasingly and explicitly examine 
the influence of corporations on public health policy, 
research and practice.3 Approaches have recently been 
developed to analyse this influence systematically. The 
‘Corporate Permeation Index’ developed by Lima and 
Galea measures “the extent to which corporations are 
embedded in the political, legal, social, economic and 
cultural fabric of a country”.17 This index seeks to quan-
tify the penetration of corporations in a given country, 
and was recently implemented for 148 countries over 
the period 2010–5.17 The results showed extensive inter-
national variation.17 The WHO, as well as institutions in 
academia and civil society, have made recommendations 
to identify and monitor the influence of the tobacco 
industry on public health policy, research and prac-
tice.18–20 Mialon et al built on this work and developed 
a step- by- step approach to monitor the CPA of the food 
industry within countries, using publicly available infor-
mation.11 To date, the approach has been implemented 
in more than 20 countries.21–27 One commonly identified 
drawback of such approaches is that they are limited by 
a lack of relevant and comprehensive publicly available 
information for most industries other than tobacco, 
where millions of internal documents are now freely avail-
able to the public.21 23 24 27 Evidence of this influence for 
other industries is typically sparse and not systematically 
compiled. It is obtained from a range of sources, including 
internal documents, primarily leaked by whistle- blowers, 
publicly available information (eg, from media releases, 
companies websites, data on lobbying, and so on) and 
interviews with those who interact with these companies.
National health authorities and civil society organisa-
tions have increasingly been concerned with the weak-
ening, delay and obstruction of public health policies 
due to harmful corporate practices.2 28 29 There is also 
increasing awareness and acceptance among the public 
health community, particularly in high- income countries, 
that interactions with these industries require extreme 
caution, and, at the minimum, transparency coupled with 
a detailed understanding of their mode of operation.30 31 
The public health community looks for inspiration to 
the WHO Framework Convention on Tobacco Control 
(FCTC),32 with recent calls for a Framework Convention 
on Food Systems (FCFS)3 and a Framework Convention 
on Alcohol Control (FCAC).33 Article 5.3 of the FCTC bars 
any interactions between governments and the tobacco 
industry except for implementing tobacco control, led by 
public health officials.32 As of December 2018, 181 coun-
tries had ratified the WHO FCTC, covering 90% of the 
world population.34 The extent of implementation of key 
FCTC regulatory measures in countries is significantly 
associated with lower smoking prevalence.35 However, the 
tobacco industry, often through pseudo- scientific front 
groups, still wields influence that allows it to avoid or 
water down regulatory initiatives.36
The demand for mechanisms to protect the policy 
process from undue corporate influence is growing. One 
example of how this became evident is when, in 2012, 
Member States requested the World Health Assembly 
(Resolution WHA65.6) to develop risk assessment, disclo-
sure and management tools to safeguard against conflicts 
of interest (COI) in policy development and implementa-
tion of nutrition programmes.37 The WHO also recently 
declared that it would no longer partner with alcohol 
industry actors during the development of policies to 
reduce harmful drinking.38 The need for guidance on 
how to address and manage undue influence from corpo-
rations is also evident in research and practice.39 40
Identification and monitoring of the industry influence 
on public health policy, research and practice is a neces-
sary but insufficient step in protecting and promoting 
public health. It is essential that international organisa-
tions, governments, academia, the media and the civil 
society are equipped to tackle potential threats to global 
health. Our study objective was, therefore, to identify 
mechanisms for addressing and/or managing the influ-
ence of corporations on public health policy, research 
and practice, as well as examples of where these mecha-
nisms have been adopted.
MethODs
We conducted a scoping review, where we searched 
scientific publications (peer- reviewed articles, letters 
to the editor, commentaries, and so on) and reports 
from governments, international organisations and civil 
society. We excluded books, as well as presentations from 
conferences, and other events where no full articles were 
available.
A scoping review was deemed to be the most suitable 
method for this study as we intended to summarise 
evidence from a heterogeneous body of research, from 
academia, governments, civil society organisations and 
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other actors in public health.41 A scoping review also 
advances knowledge in an emerging field of research, 
which is the case for mechanisms to address the influ-
ence of corporations on public health.41 In addition, 
it helps examine the nature of available research and 
research gaps in the literature, which could inform future 
research.41
We used the Preferred Reporting Items for System-
atic Reviews and Meta- Analyses (PRISMA) Extension for 
Scoping Reviews (PRISMA- ScR, see online supplemen-
tary file 2) to prepare our scoping review protocol and 
our manuscript. The protocol was revised by the research 
team and registered with the Open Science Framework 
on 27 May 2019 (https:// osf. io/ xc2vp).
In our scoping review, the term ‘mechanism’ refers to: 
policies, regulations, guidelines, codes of conduct, frame-
works, standards, initiatives or other tools to address and/
or manage the influence of corporations on public health 
policy, research and practice.
The terms ‘industry’ and ‘corporations’ are employed 
interchangeably in this manuscript to refer to the manu-
facturers, wholesalers, retailers, distributors, food service 
providers, as well as producers of raw material. We also 
include those organisations acting on their behalf, overtly 
or covertly, including some trade associations, public rela-
tions firms, ‘philanthropic’ organisations, research insti-
tutions and other individuals and groups.
Database searches
Search strategy
The development of the search strategy was informed 
by previous systematic and scoping reviews that analysed 
the influence of corporations on public health policy, 
research and practice7 12 13 or that presented mechanisms 
to address and/or manage that influence (for the food 
industry, for example40). We used keywords and Medical 
Subject Headings (MeSH) terms. The search strategy was 
developed with the help of a librarian at the University of 
Antioquia, Colombia.
We conducted systematic searches in five databases:
 ► Web of Science Core Collection (Web of Knowledge 
interface);
 ► BIOSIS (Web of Knowledge interface);
 ► MEDLINE (Web of Knowledge interface);
 ► Embase (Embase interface);
 ► Scopus (Scopus interface).
The terms used in the search strategy were tailored to the 
requirements of each database and included ((corporat* 
or industr* or compan* or business* or firm*) AND 
(address* or manag* or ‘guid*’ or ‘codes of conduct’ or 
framework* or standard* or governance)). In addition, 
we searched the following key terms in the titles only, 
as a broader search yielded too many irrelevant results: 
((diet or nutrition or food or obesity or alcohol or drink 
or pharma* or gambl* or tobacco or smok* or cigarette* 
or oil or ‘public health’) AND (interact* or conflict* or 
‘public*private” or poli* or legislat* or lobb*)).
Our search strategy for Web of Science Core Collection 
(Web of Knowledge interface) was:
TO= ((corporat* or industr* or compan* or business* 
or firm*) AND (address* or manag* or “guid*” or “codes 
of conduct” or framework* or standard* or governance)) 
AND TI= ((diet or nutrition or food or obesity or alcohol 
or drink or pharma* or gambl* or tobacco or smok* 
or cigarette* or oil or “public health”) AND (interact* 
or conflict* or “public*private” or poli* or legislat* or 
lobb*))
Indexes=SCI- EXPANDED, SSCI, A&HCI, CPCI- S, 
CPCI- SSH, BKCI- S, BKCI- SSH, ESCI, CCR- EXPANDED, 
IC Timespan=2003 to 2019
The search strategies for other databases are presented 
in online supplementary file 3. Databases were searched 
on 4 June 2019.
Eligibility criteria
To be included in this review, publications had to:
 ► Be published in 2003 and later, when the WHO- FCTC 
came into effect;
 ► Be published in English, French, Spanish, Portuguese, 
or Italian—languages for which members of our team 
had at least working proficiency;
 ► Analyse, use, compare, propose or evaluate one or 
several mechanisms for addressing and/or managing 
the influence of corporations on public health policy, 
research and/or practice;
 ► Focus on the influence of the alcohol, food, gambling, 
oil, pharmaceutical and/or tobacco industries on 
public health policy, research and practice;
 ► Focus on mechanisms at the international, regional 
(eg, Europe) or national level.
Selection of sources of evidence
All citations identified were downloaded and imported to 
the web- based bibliographic manager F1000 Workspace, 
where duplicate citations were removed. Data extraction 
and analysis were led by the first author. MM screened 
all titles and abstracts, when available, for eligibility. GS 
double- screened 10% of the material. MM then obtained 
the full- texts of potential eligible material. When publi-
cations were not available online, MM contacted the 
first authors of the materials to obtain a copy of the 
documents (n=13). MM assessed the eligibility of that 
material against the eligibility criteria. GS assessed the 
eligibility of 10% of the documents. Disagreement was 
resolved by consensus after discussion between MM and 
GS. For documents that were included in our review, MM 
searched their bibliographic reference sections (back-
ward searches) and searched documents that were citing 
them; using Scopus (forward searches) to identify addi-
tional relevant material.
Additional searches
Twenty- eight institutions and networks working on the 
industry influence on public health policy, research and 
practice, as detailed in online supplementary file 1, were 
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contacted in May 2019 to identify additional mechanisms 
and examples. These institutions were identified through 
the authors’ networks. Only one of these institutions 
answered our requests. In addition, we identified mecha-
nisms and examples of their adoption from our collective 
experience working on the influence of corporations on 
public health policy, research and practice.
We included documents from the grey literature, 
including from international agencies (eg, WHO, World 
Bank, and so on), national government agencies, univer-
sities, academic journals, international professionals asso-
ciations, the media, research funders and civil society 
organisations.
Data charting process and data items
Data was charted by MM in an Excel table, and the vari-
ables for which data were sought were:
 ► Whether or not the study was funded by corporations 
or had authors that were employed by corporations 
in the alcohol, food, gambling, oil, pharmaceutical 
or tobacco industries (as disclosed in the documents 
identified through our searches);
 ► Individuals and institutions targeted by the mecha-
nism: governments and international organisations 
(with details about specific institutions targeted by the 
mechanisms within these organisations); academia 
(including researchers, universities, scientific jour-
nals, research funders, ethics review boards, and so 
on), the media and the civil society;
 ► Details about the mechanism for addressing and/or 
managing the influence of corporations on public 
health policy, research and practice, including the 
type of mechanism described;
 ► Information about specific examples where the 
mechanism has been adopted, either fully or to some 
extent, including the name of the country, the name 
of the policy and the URL.
synthesis of results
We identified four broad types of mechanisms for 
addressing and managing the influence of corporations 
on public health policy, research and practice, through 
our interpretation of the data, and as presented at the 
beginning of our results section. Most mechanisms iden-
tified in this review pertain to one or more of these four 
broad categories
We present the results of our review in two tables: one 
table with mechanisms for governments and interna-
tional organisations and one table with mechanisms for 
academia, the media and civil society. We decided to first 
present data for individuals and institutions in govern-
ments as they may have a legal obligation to address 
undue influence from corporations and conflicts of 
interest, while this might not be the case for other actors 
in public health.
We then grouped each mechanism by institution 
(ministries, universities, academic journals, and so on), in 
no specific order. Where multiple mechanisms targeting 
particular aspects of corporate influence were identi-
fied, we only included the most stringent mechanisms, as 
determined by ourselves.
We also include examples where these mechanisms have 
been adopted, fully or to some extent, as identified in the 
documents collected during our systematic searches or as 
identified through additional searches. The URLs for the 
examples included in our scoping review are available in 
online supplementary file 4. We made a particular effort 
to represent a broad range of countries from different 
regions of the globe in these examples, although our list 
is non- exhaustive.
exclusion criteria
We excluded documents funded by corporations or whose 
authors were employed by corporations in the alcohol, 
food, gambling, oil, pharmaceutical and tobacco indus-
tries (as disclosed in the documents identified through 
our searches), as these represented an inherent COI 
in the development of mechanisms to address and/or 
manage the influence of these industries.
In our analysis, we excluded mechanisms:
 ► that were proposed or developed by the industries 
mentioned above when these were presented among 
other mechanisms in non- industry funded documents 
(eg, reports from multi- stakeholders platforms);
 ► only addressing marketing practices, for example:
 – the sponsorship of sport;
 – the interactions between pharmaceutical com-
panies and doctors, pharmacists and other 
healthcare professionals (including during their 
training) when those have the sole purpose of sell-
ing products.
 ► targeted at corporations for managing their interac-
tions with government, academia, the media and the 
civil society;
 ► targeting corporate practices that are almost univer-
sally illegal, such as criminal activity and bribery of 
government officials, although we recognise that these 
other forms of influence exist. These are beyond the 
scope of this manuscript.
We also excluded documents that did not analyse, use, 
compare, propose or evaluate a mechanism per se, but 
instead discussed its adoption in a specific context (for 
example the adoption in nine countries of a transparency 
policy for the interactions between healthcare profes-
sionals and the pharmaceutical industry42). In this case, 
we used these examples in our results section to illustrate 
instances where a mechanism was adopted.
Patient and public involvement statement
Patients and the public were not involved in this research.
results
The PRISMA flow diagram for our scoping review is 
presented in figure 1. In total, 2015 documents were iden-
tified in the databases searches (excluding duplicates). 
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Figure 1 PRISMA (Preferred Reporting Items for Systematic 
Reviews and Meta- Analyses) flow diagram.
After screening of their titles and abstracts, 1998 docu-
ments were excluded and 17 were included. In addition, 
6 documents were identified through backward searches 
and 12 documents were found through additional 
searches. No new documents were identified through 
forward searches. In total, 35 full- texts were included 
for analysis. Subsequently, two articles were excluded 
because they did not present mechanisms for addressing 
and/or managing the industry influence; one article 
was excluded because we could not retrieve its full- text, 
despite contacting its first author; and one article was 
excluded because it only discussed marketing practices.
In total, 31 documents were included in our scoping 
review. All references included in our scoping review 
came from high- income countries, in particular the USA 
(n=9). Eight documents were published by international 
organisations based in France, Switzerland and the USA. 
Only eight documents were peer- reviewed articles. Other 
documents included letters to the editors, commentaries 
and other pieces in scientific/clinical journals, as well as 
reports by national and international organisations. Nine 
documents discussed mechanisms to address and/or 
manage the influence of all sorts of industries. The other 
documents targeted specific industries (these categories 
are not mutually exclusive): six for the alcohol industry; 
seven for the food industry; five for the gambling 
industry; five for the pharmaceutical industry; and six for 
the tobacco industry. None of the documents discussed 
mechanisms to address and/or manage the influence 
of the oil industry. Most documents included mecha-
nisms for governments (n=17) and academia (including 
researchers, universities, scientific journals, research 
funders, ethics review boards, and so on) (n=13). Three 
documents proposed mechanisms for civil society and 
one for the media. We found many examples where these 
mechanisms have been adopted, as described below.
Many of the mechanisms identified in our review, as 
discussed in the sections below, focus on the management 
of COI. COI provisions might not be sufficient to reduce 
industry influence and that interactions with industry 
can be ethically problematic and may influence public 
health policy, research and practice even when COI poli-
cies are not implemented.43 44 We identified four main 
types of mechanisms to address undue influence from 
corporations (categories are not mutually exclusive): (i) 
managing the interactions with industry and COI; (ii) 
increasing transparency about these interactions and 
COI; (iii) identifying, monitoring and educating third 
parties in academia, civil society and the media about the 
practices of corporations and associated risks to public 
health; and (iv) prohibiting any interaction with industry. 
There are other types of mechanisms discussed in the 
literature, such as the protection of whistle- blowers, or 
mandatory taxes for companies to be used by an inde-
pendent organisation to fund public health research and 
practice, as detailed below.
governments and international organisations
International organisations and governments have a 
mandate to protect and promote public health. Govern-
ments are in charge of the initiation, development, 
implementation and evaluation of public health policies. 
As such, they are a primary target of corporations whose 
profits might be threatened by such policies, during all 
phases of the policy cycle but in particular during initia-
tion and development of policies.
In our scoping review, we identified 23 mechanisms for 
addressing and/or managing the influence of corpora-
tions on governments and international organisations 
(table 1).
There are growing concerns about how international 
organisations, including the WHO, engage with corpora-
tions and in response, the WHO has recently addressed 
some of these concerns, most notably in its Framework for 
Engagement with non- State Actors (FENSA).37 45 There is 
criticism of FENSA, as it could be interpreted as an invi-
tation for increased collaboration between the WHO and 
industry, suggesting that this is acceptable if managed as per 
WHO guidelines.46
The Organisation for Economic Co- operation and Devel-
opment (OECD) published several documents that are rele-
vant for the current scoping review, including guidelines 
for the management of conflicts of interest.47 48 In 2017, it 
developed a framework for ‘Preventing Policy Capture’.49 
It also published a series of reports on lobbying regula-
tion50 and on the funding of political parties and elections 
campaigns.51
The World Bank developed a ‘Public Accountability 
Mechanisms Initiative’, which includes specific recommen-
dations and “provides assessments of countries’ in- law and 
in- practice efforts to enhance the transparency of public 
administration and the accountability of public officials”.52
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Many countries and international organisations have 
internal policies and procedures to manage COI, some 
of which require the disclosure of these interests to the 
public. There are, in addition, existing tools that can help 
in assessing risks to individuals and institutions in public 
health when they are considering engaging with corpora-
tions, such as the Purpose, Extent, Relevant- harm, Iden-
tifiers, Link (PERIL) indicators53 or the decision- making 
tool developed by the WHO for the prevention and 
management of COI in nutrition programmes.54
For 22 of the 23 mechanisms identified in our scoping 
review, we found evidence of their adoption, in different 
parts of the world, to various degrees. Many of the 
examples identified in table 1 refer to the interactions 
of governments and international organisations with 
the tobacco industry, following the ratification of the 
WHO FCTC. However, no country, to date, has entirely 
restricted the influence of corporations on public policy.
Academia, the media and the civil society
We identified, through our systematic searches, 26 mech-
anisms for addressing and managing the influence of 
corporations on academia, the media and the civil society 
(table 2).
Individuals and institutions in academia, the media and 
the civil society (including public health professionals, 
civil society organisations, and so on) often engage with 
corporations, through the sponsorship of events, funding 
of research project, scientific awards or other types of 
interactions. These are standard practices, and while 
there are multiple reasons for them to happen, the scar-
city of public funding and the vast resources of corpora-
tions are often mentioned.43 There is, however, growing 
concern that the influence of the industry poses threats 
to the independence, integrity and credibility of these 
individuals and institutions.29 55–61
We found examples, from across the world, where these 
21 of these 26 mechanisms have been adopted. Some 
universities refuse funding from the tobacco industry; 
some make transparent interactions between their staff 
members, students and corporations. Many institutions in 
academia and civil society have conflicts of interest poli-
cies, which is also the case for some scientific journals and 
professionals associations. The provision of education in 
universities, conferences and other meetings and to jour-
nalists was also cited.
DisCussiOn
Our searches identified 49 mechanisms for addressing 
and/or managing the influence of corporations on 
public health policy, research and practice. The primary 
purposes of the mechanisms identified are to manage 
conflicts of interest and increase the transparency of 
public- private interactions. Based on publicly available 
information, we found that 43 of these mechanisms had 
been adopted, although we could not confirm that they 
had all been implemented and had been determined to 
be effective.
There is currently limited research in this area, with 
only a few peer- reviewed scientific articles published 
in the literature. We also noted that there is a lack of 
research from low- income or middle- income countries. 
We identified limited evidence on mechanisms targeted 
at the media and the civil society, compared with those 
targeted at governments and academia. We found no 
information for schools on ways to address and manage 
the influence of corporations on their institutions, in 
relation to public health (for example, through the provi-
sion of health or nutrition education or physical activity 
programmes). We identified limited information about 
mechanisms that could address the influence of corpo-
rations; most mechanisms seek to manage that influence 
(through transparency, for example). Managing the 
influence of corporations is an important first step, but 
is not sufficient, or could even be counterproductive in 
some circumstances.44
To our knowledge, this review is the first attempt to 
develop an inventory of mechanisms to address and 
manage the influence of corporations on public health 
policy, research and practice. Among its strengths is its 
breadth. Although we limited our searches to mecha-
nisms developed to address and/or manage the influence 
of the alcohol, food, gambling, oil, pharmaceutical and 
tobacco industries, many of the mechanisms identified in 
our review were developed with no restriction on the type 
of industries targeted. Hence this inventory may help in 
building efforts to address and/or manage the influence 
of all types of industries.
The list compiled here is non- exhaustive and by nature, 
subject to changes, as an increasing number of govern-
ments and other institutions take measures to prevent 
undue influence from industry. It rather was intended to 
be a first attempt to identify mechanisms that exist across 
the globe, as well as examples where these mechanisms 
have been adopted. It thus provides a firm footing for 
further work in this area.
In this scoping review, we did not assess the quality of 
the included studies, as we only used them to identify 
mechanisms. In addition, mechanisms at the subnational 
level were not included here and might be the subject of 
future investigations. Moreover, we excluded work funded 
by the industry, but it is possible that some authors did 
not declare their sources of funding in the publications. 
In this case, their work is included in our analysis, which 
represents a COI with regards to the issues at stake.
Ideally, corporations should refrain from influencing 
public health policy, research and practice. Governments, 
international organisations, academia, the media and the 
civil society should avoid interacting with corporations 
whose interests risk damaging their independence, integ-
rity and credibility.43 However, in reality, these interactions 
often are the default approach in public health, prob-
ably driven by a strong influence exerted by businesses.43 
These interactions, the reasons for them to happen and 
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associated risks for public health were recently discussed 
in the literature.43 Public institutions sometimes lack 
resources, particularly financial resources, to address 
urgent public health issues.43 Academic institutions might 
want to contribute to the economic development in their 
country, thus partnering with corporations.43 The current 
situation is perhaps challenging, but there is scope (and 
need) for change. Many of the examples we identified in 
our review related to the implementation of the WHO 
FCTC, the only global treaty that explicitly addresses the 
interference of an industry with public health policy. The 
proposed FCFS and FCAC are therefore potential solu-
tions to address and manage the influence that vested 
interests could have on public health policy, research 
and practice. If adopted and evaluated more widely, 
many of the mechanisms described in this manuscript 
could contribute to efforts to prevent and control non- 
communicable diseases.
More research on each of these mechanisms is needed, 
including on their effectiveness in addressing and/or 
managing the influence of corporations on public health 
policy, research and practice. There is a need to under-
stand if these mechanisms are effective in addressing the 
influence of all industries, or of only some industries, and 
then study the political, social and other factors respon-
sible for these differences. Collectively, public health 
professionals might also develop, in the future, new mech-
anisms not described in our manuscript. Some countries 
have already adopted some of the mechanisms proposed 
in this manuscript; others have done little, including 
countries facing strong resistance to developing and 
implementing them. An evaluation of the implementa-
tion of these mechanisms, which could include a bench-
marking exercise, is therefore needed and will inform 
governments, universities and other actors in public 
health. In addition to these mechanisms, a module on 
‘corporations and health’ could be part of the curriculum 
for professionals being trained in public health policy, 
research or practice. Conferences and other meetings 
of public health professionals should also be used as a 
platform where to discuss the influence of the industry 
on public health policy, research and practice. This may 
be particularly important in the case of academic confer-
ences which involve extensive resources and input from 
and partnerships with corporations, such as nutrition and 
gambling conferences.
In conclusion, corporations have significant economic 
and political power, which may, in some circumstances, 
be detrimental to public health. We identified several 
mechanisms that could help address and/or manage that 
influence. The development, implementation and moni-
toring of these mechanisms seem crucial to protect public 
health from the commercial interests of industry actors.
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